Advances in therapeutical strategies for neurodegenerative diseases would reduce the burden related to these diseases. To test effectively compounds for diseases such as Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), or Alzheimer’s disease (AD) bring therapy to individuals as early as possible, there is an urgent need for the establishment of standards and networks for iden...